6.20 +0.06 (0.98%)
After hours: 4:25PM EDT
|Bid||6.06 x 1100|
|Ask||6.14 x 900|
|Day's Range||5.92 - 6.16|
|52 Week Range||2.64 - 24.90|
|Beta (3Y Monthly)||-2.80|
|PE Ratio (TTM)||N/A|
|Earnings Date||Aug 8, 2018 - Aug 13, 2018|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||20.00|
Arcadia Biosciences, Inc. (RKDA), a food ingredient company and proven leader in agricultural innovation to improve the quality and nutritional content of crops, announced today that Randy Shultz, Ph.D. has joined the company’s leadership team as head of research and development. Shultz has nearly 20 years of experience in plant science and agricultural biotechnology. Shultz was the first key scientific hire at Inari, and played an instrumental role in building a scalable R&D platform and developing a foundational intellectual property estate.
DAVIS, Calif. (AP) _ Arcadia Biosciences Inc. (RKDA) on Wednesday reported a loss of $646,000 in its fourth quarter. On a per-share basis, the Davis, California-based company said it had a loss of 14 cents.
—Company delivers regulatory, scientific and commercial progress in four crops, and launches new strategy in cannabis—
Arcadia Biosciences, Inc. (RKDA), an agricultural food ingredient company and proven leader in improving the quality and nutritional content of crops, today announced that it will be featured as a presenting company at The Spring Investor Summit. Raj Ketkar, Arcadia’s president and CEO, will present a business overview at 1:00 p.m. EDT on Tuesday, April 2, 2019, and will be available for meetings with investors. Attendees may schedule a meeting by logging into the conference website at www.springinvestorsummit.
Verdeca, a joint venture between Arcadia Biosciences, Inc. (RKDA) and Bioceres Crop Solutions Corp. (NYSE American: BIOX), introduced pre-commercial soybean varieties carrying the drought-tolerant HB4® trait to growers in Argentina at the country’s largest farm show, Expoagro, held March 12th to 15th in San Nicolas, Argentina. The soybean varieties deliver two layers of value for growers: drought and herbicide tolerance. The HB4 trait is Verdeca’s first release from a pipeline of yield and quality traits and demonstrates the company’s ability to bring innovation to soybean growers.
Arcadia Biosciences, Inc. , an agricultural food ingredient company, today announced that it will release its 2018 fourth-quarter and full-year financial and business results after market close on March 27, 2019.
Shares of Davis-based Arcadia Biosciences Inc. rose 13 percent on news that its safflower nutritional supplement for cats has been granted approval from the Food and Drug Administration.
Expanding on the United States Food And Drug Administration’s (FDA) 2017 approval of gamma linolenic acid (GLA) safflower oil as both safe and nutritious for use in canine diets, Arcadia Biosciences, Inc. (RKDA), an agricultural food ingredient company, today announced that the FDA has granted further approval of the ingredient for use in cat food.
Arcadia Biosciences (RKDA) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
The license in question allows for the cultivation of industrial hemp. Arcadia CFO Matt Plavan, who is also president of Arcadia Specialty Genomics, told Benzinga it’s the company's ambition to extend its reputation as a leading science-driven crop improvement company to cannabis.
Shares of Arcadia Biosciences Inc. soared 17% in premarket trade Monday, after the food ingredients and nutritional oils company said it was granted its first Industrial Hemp Pilot Progam license in Hawaii. The license allows Arcadia Specialty Genomics, the company's cannabis-focused business unit launched last week, to begin research and cultivation of hemp, planted on ten acres of leased land. "Industrial hemp, along with all strains of cannabis, are decades behind other agricultural crops in terms of improved plant genetics," said Arcadia Chief Financial Officer Matt Plavan. "With the explosive market growth projected in the industrial hemp and derivative markets, growers will need the very best hemp strains to meet demand, minimize waste, and ensure consistent quality." The stock has soared 83.5% over the past three months, while the ETFMG Alternative Harvest ETF has rallied 32.1% and the S&P 500 has gained 3.8%.
The company’s new cannabis-dedicated operating unit, Arcadia Specialty Genomics, will commence research this April with a new 10-acre hemp cultivation facility. Building on last week’s launch of Arcadia Specialty Genomics™, a new cannabis-dedicated division of the agricultural food ingredient company, Arcadia Biosciences, Inc. (RKDA) today announced that it has been granted an Industrial Hemp Pilot Program (“HIHPP”) License by Hawaii’s Department of Agriculture. The license allows for the cultivation of industrial hemp in Hawaii for the purposes of agricultural and academic research.
Shares of Davis-based plant trait research firm Arcadia Biosciences Inc. rose 49 percent Thursday on the news that the company will optimize and commercialize cannabis for hemp production.
Agritech company Arcadia Biosciences Inc (NASDAQ: RKDA ) announced Thursday that it's launching a cannabis business unit, sending the company's shares to an eight-month high . What Happened Davis, California-based ...
Shares of Arcadia Biosciences Inc. rocketed 59% in very active premarket trade, after the agricultural food ingredient company announced a new business unit focused on the cannabis. Volume ballooned to 765,000 shares, already nearly 5-times the full-day average. The company said it will apply its expertise in breeding to improve the quality and nutritional content of wheat and soybeans, for the standardization of cannabis plant content, quality, climate resiliency and yield. The company said it will conduct its business only in federal and state markets in which its cannabis activities are legal. "Within the rapidly growing legal cannabis industry, we see enormous opportunity in--and demand for--improved plant quality, productivity, consistency and resilience," said Chief Executive Raj Ketkar. The stock has rallied 28.6% over the past three months through Wednesday, while the ETFMG Alternative Harvest ETF has climbed 24.6% and the S&P 500 has gained 1.8%.
Arcadia Specialty Genomics to bring standardization and optimization to America’s cannabis crop with a focus on improved plant quality, resiliency and yield. Arcadia Biosciences, Inc. (RKDA), an agricultural food ingredient company and proven leader in leveraging advanced, proprietary breeding techniques to improve the quality and nutritional content of wheat and soybeans, today announced the company will apply its expertise to a new crop: cannabis. With the establishment of Arcadia Specialty Genomics™, the company is dedicating a first-of-its-kind strategic business unit to the optimization and standardization of cannabis plant content, quality, climate resiliency and yield.
The big shareholder groups in Arcadia Biosciences, Inc. (NASDAQ:RKDA) have power over the company. Generally speaking, as a company grows, institutions will increase their ownership. Conversely, insiders often decrease theirRead More...
Demonstrating its commitment to advancing its GoodWheat™ portfolio of novel, non-GM wheat ingredients with unique health benefits to commercialization, Arcadia Biosciences, Inc. (RKDA), an agricultural food ingredient company, today announced additional progress in the development of its supply chain, led by Grant Aldridge, the company’s new Head of Commercial Development. Since mid-2018, Arcadia has significantly expanded its grower base for unique GoodWheat varieties to provide adequate supply for its consumer and animal feed customers. To preserve the unique characteristics of GoodWheat, the company has developed a robust identity preservation system that ensures the wheat’s unique quality is maintained throughout the supply chain, from seed to food company.
Arcadia Biosciences, Inc. , an agricultural food ingredient company, today announced that it will be featured as a presenting company at NobleConXV, Noble Capital Markets’ Fifteenth Annual Investor Conference, at the W Hotel in Fort Lauderdale, Florida.
Arcadia Biosciences, Inc. (RKDA), an agricultural food ingredient company, today announced that its lawsuit in the United States District Court for the Southern District of New York against Arista Cereal Technologies, Pty. Ltd. has ended based on a jurisdictional decision by the court. The lawsuit sought to correct inventorship on key patents for Arista’s high-amylose wheat. “The vast majority of our GoodWheat™ portfolio as well as the overall target market for our wheat, soy and other nutrition and ingredient products is unaffected by our dispute with Arista.
NEW YORK, NY / ACCESSWIRE / December 11, 2018 / Arcadia Biosciences and Achaogen were two winners in the biotech arena on Monday. Achaogen soared over 20% on positive clearance news for the Thermo Scientific QMS Plazomicin Immunoassay. There was no remarkable news from Arcadia Biosciences to explain the jump.